The rheumatoid arthritis (RA) synovial pannus is characterized by a number of processes, including monocyte recruitment, leukocyte--endothelial adhesion, and angiogenesis. We have generated a novel monoclonal antibody (mAb) (mAb 4A11), which detects the blood group antigens Lewis y and H-5-2 (collectively termed the 4A11 antigen). We have shown that this antigen, in soluble form, as well as a glucose analog of H-5-2 (H-2g), are potent mediators of angiogenesis. The 4A11 antigen is selectively expressed in skin, lymphoid organs, the thymus and synovium, and is upregulated on RA synovium compared with normal synovium, suggesting a role in leukocyte recruitment and homing. We have also shown that H-2g significantly upregulates cell surface expression of the adhesion molecule intercellular adhesion molecule-1 (ICAM-1) on human dermal microvascular endothelial cells (HMVECs), but not vascular cellular adhesion molecule-1 or E-selectin. In accord with this, H-2g induces ICAM-1-mediated leukocyte--endothelial adhesion. Moreover, H-2g or the 4A11 antigen activate the endothelial janus kinase 2 (JAK2)/STAT3 pathway, as demonstrated by inhibition by chemical inhibitors of these pathways as well as antisense oligodeoxynucleotides directed against these signaling intermediates. H-2g may also signal via the Erk1/2 and PI3kinase-Akt pathways. Moreover, H-2g induced endothelial NF-κB activation, and blockade of PI3kinase or JAK2 inhibited H-2g-induced endothelial NF-κB activation. These results suggest that the H-2g and the 4A11 antigen are mediators of leukocyte--endothelial adhesion via ICAM-1.

We next sought to determine whether H-2g could induce monocyte recruitment. We performed monocyte chemotaxis *in vitro*in modified Boyden chambers. H-2g induced monocyte chemotaxis in the picomolar or greater range. *In vivo*, injection of H-2g intraperitoneally into the periotoneum of mice resulted in monocyte recruitment. The migration of monocytes *in vitro*, as with induction of HMVEC ICAM-1 expression, appeared to occur via the mitogen-activated kinase and PI3kinase pathways, but also via the Src pathway. These results suggest that H-2g and the 4A11 antigen are potent mediators of leukocyte--endothelial adhesion and monocyte recruitment, and that efforts aimed at targeting this antigen or its signaling pathways may be useful in the treatment of RA.
